RBC Comments on Biogen's (BIIB) Alzheimer's Late-Breaker
RBC analyst Michael J. Yee commented on late-breaker abstract data on Biogen's (NASDAQ: BIIB) BIIB-037. Yee said his first impression ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
